In a cohort study from Czech, the JAK2 mutation was detected in 145 patients with MPN, 40 of whom had thrombosis (27.6%), which was significantly higher than those without (8.0%, p = 0.001). The gene discussed is JAK2; the disease is myeloproliferative neoplasm.